#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11744	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2105	551.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1412	1412	C	704	C,G	682,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11744	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2105	551.6	0	HET	.	.	.	C207T	.	207	207	C	435	435	C	644	C,T	498,109	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11744	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2105	551.6	0	HET	.	.	.	C451T,G	.	451	451	C	679	679	C	682	C,T,G	504,158,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21406	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3495	609.0	0	.	n	.	0	T695C	SNP	695	695	T	960	960	C	693	C,T	654,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21406	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3495	609.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2236	2236	C	646	C	621	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21406	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3495	609.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2310	2310	A	617	A	597	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21406	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3495	609.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2862	2862	C	656	C	629	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21406	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3495	609.0	0	HET	.	.	.	A1638G	.	1638	1638	A	1903	1903	A	670	A,G	514,140	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1344	folP	855	855	100.0	folP.l15.c4.ctg.1	1585	84.0	1	SNP	p	R229S	1	.	.	685	687	AGC	993	995	AGC	135;133;134	A;G;C	131;129;126	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3726	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3367	109.9	1	SNP	p	S91F	1	.	.	271	273	TTC	564	566	TTC	124;122;122	T;T;C	119;120;119	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3726	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3367	109.9	1	SNP	p	D95G	1	.	.	283	285	GGC	576	578	GGC	113;114;113	G;G,A;C	109;109,2;107	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3726	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3367	109.9	1	SNP	p	G95N	0	.	.	283	285	GGC	576	578	GGC	113;114;113	G;G,A;C	109;109,2;107	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1288	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1271	100.6	1	SNP	p	G45D	0	.	.	133	135	GGC	430	432	GGC	172;173;171	G;G;C	166;167;164	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	712	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1033	68.6	0	.	n	.	0	A197.	DEL	197	197	A	540	540	A	167	A	162	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3412	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3133	108.5	1	SNP	p	D86N	0	.	.	256	258	GAC	746	748	GAC	137;136;137	G,A;A;C	131,1;125;133	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3412	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3133	108.5	1	SNP	p	S87R	1	.	.	259	261	CGT	749	751	CGT	138;138;138	C;G;T	134;132;130	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3412	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3133	108.5	1	SNP	p	R87W	0	.	.	259	261	CGT	749	751	CGT	138;138;138	C;G;T	134;132;130	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3412	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3133	108.5	1	SNP	p	R87I	0	.	.	259	261	CGT	749	751	CGT	138;138;138	C;G;T	134;132;130	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3412	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3133	108.5	1	SNP	p	S88P	0	.	.	262	264	TCC	752	754	TCC	138;136;136	T;C;C	133;131;132	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3086	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2658	115.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1552	1554	GGC	157;155;152	G;G;C	147;147;144	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3264	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2407	134.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1252	1254	GCC	177;174;176	G;C;C	169;169;170	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3264	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2407	134.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1255	1257	ATG	177;180;178	A;T;G	171;172;173	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3264	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2407	134.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1267	1269	ACC	178;178;179	A;C;C	167;168;169	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3264	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2407	134.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1267	1269	ACC	178;178;179	A;C;C	167;168;169	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3264	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2407	134.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1768	1770	ACC	181;182;185	A;C;C	166;174;177	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3264	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2407	134.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1822	1824	GCG	158;157;156	G;C;G	154;152;151	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3264	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2407	134.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1822	1824	GCG	158;157;156	G;C;G	154;152;151	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3264	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2407	134.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1945	1947	GGT	123;123;122	G;G,C;T	119;116,1;118	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3264	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2407	134.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1954	1956	AGC	118;115;113	A,G;G;C	111,1;113;109	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3264	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2407	134.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1972	1974	CCG	102;104;103	C,G;C,G;G	87,5;91,2;90	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4478	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3236	137.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1692	1694	CCG	150;151;154	C;C;G	139;145;144	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1628	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1916	84.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	642	642	C	121	C	109	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	200	porB1a	984	276	90.71	porB1a.l15.c30.ctg.2	341	17.4	0	.	p	.	0	H217N	NONSYN	649	651	CAT	90	92	AAT	9;9;9	A;A;T	8;7;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	200	porB1a	984	276	90.71	porB1a.l15.c30.ctg.2	341	17.4	0	.	p	.	0	D218N	NONSYN	652	654	GAT	93	95	AAT	9;9;9	A;A;T	9;9;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	200	porB1a	984	276	90.71	porB1a.l15.c30.ctg.2	341	17.4	0	.	p	.	0	V226A	NONSYN	676	678	GTA	117	119	GCA	10;10;10	G;C;A	9;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	200	porB1a	984	276	90.71	porB1a.l15.c30.ctg.2	341	17.4	0	.	p	.	0	.	MULTIPLE	700	702	ACT	140	142	GTA	6;6;6	G;T;A	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	200	porB1a	984	276	90.71	porB1a.l15.c30.ctg.2	341	17.4	0	.	p	.	0	N237fs	FSHIFT	709	709	A	149	149	A	5	A	5	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2410	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1479	160.2	1	SNP	p	G120K	1	.	.	358	360	AAG	674	676	AAG	179;179;181	A;A,G;G	171;171,1;166	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2410	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1479	160.2	1	SNP	p	A121N	1	.	.	361	363	AAC	677	679	AAC	181;180;180	A;A;C,A	172;171;167,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2410	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1479	160.2	1	SNP	p	N121D	0	.	.	361	363	AAC	677	679	AAC	181;180;180	A;A;C,A	172;171;167,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8486	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4845	174.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	950	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	962	97.7	1	SNP	p	V57M	1	.	.	169	171	ATG	488	490	ATG	183;183;179	A;T;G	178;178;175	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
